Thrombo-Embolism in Patients with Abnormally Short Activated Partial Thromboplastin Time

Rajalaxmi McKenna; Fedor Bachmann; Miguel Miro-Quesada

doi:10.1055/s-0038-1651907

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1977; 38(04): 0893-0899
DOI: 10.1055/s-0038-1651907

Original Article

Schattauer GmbH

Thrombo-Embolism in Patients with Abnormally Short Activated Partial Thromboplastin Time

Rajalaxmi McKenna

¹Thrombosis Research Unit, Section of Hematology, Department of Medicine, Rush-Presbyterian-St. Luke’s Medical Center, Chicago, Illinois, U.S.A.

,

Fedor Bachmann^*

¹Thrombosis Research Unit, Section of Hematology, Department of Medicine, Rush-Presbyterian-St. Luke’s Medical Center, Chicago, Illinois, U.S.A.

,

Miguel Miro-Quesada

¹Thrombosis Research Unit, Section of Hematology, Department of Medicine, Rush-Presbyterian-St. Luke’s Medical Center, Chicago, Illinois, U.S.A.

› Institutsangaben

Abstract

Summary

Patients with a shortened activated partial thromboplastin time (APTT) of less than 29 sec (≥2.5 SD below the mean) were followed for the development of peripheral deep vein thrombosis by clinical findings. Perfusion lung scans were performed in patients with clinical symptoms suggesting pulmonary embolism. 23 of 100 patients in this prospective study developed thrombo-embolism (TE). This represents a tenfold increase over the overall incidence of 2.2% in medical and surgical patients during the study period. Shortened APTT’s were encountered most commonly in patients with disseminated malignancy and in surgical patients. Post-op er ative patients with an APTT of ≤ 28 sec were at high risk for the subsequent development of TE (43 %). There was a correlation between frequency of shortened APTT, degree of shortening of the APTT and incidence of TE. Patients with APTT’s of ≤ 28 sec on at least three occasions or ≤ 25 sec on at least one occasion had a 53% incidence of TE. Prophylactic low dose heparin therapy is therefore recommended for all patients who show a persistent mild shortening of the APTT or a severe shortening of the APTT on at least one occasion during periods of high risk, e.g. during immobolization or after surgery.

Volltext

Referenzen

References
1 Alkjaersig N, Fletcher A, Burstein R. 1975; Association between oral contraceptive use and thrombo-embolism: a new approach to its investigation based on plasma fibrinogen chromatography. American Journal of Obstetrics and Gynecology 122: 199.
2 Bachmann F, McKenna R, Cole E. R. et al. 1975; The hemostatic mechanism after open-heart surgery. I. Studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation. Journal of Thoracic and Cardiovascular Surgery 70: 76.
3 Clark C, Cotton L. T. 1968; Blood flow in deep veins of leg. Britisch Journal of Surgery 55: 211.
4 Detakats G. 1943; A test of the clotting mechanism. Surgery, Gynecology and Obstetrics with International Abstracts of Surgery 77: 31.
5 Eastham R. D, Morgan E. H. 1964; Plasma hypercoagulability in patients with carcinoma and after haemorrhage. Lancet II: 543.
6 Flanc E, Kakker V. V, Clarke M. B. 1968; The detection of venous thrombosis of the legs using ¹²⁵I-labelled fibrinogen. British Journal of Surgery 55: 742.
7 Gallus A. S, Hirsch J, Gent M. 1973; Relevance of pre-operative and post-operative blood tests to post-operative leg-vein thrombosis. Lancet II: 805.
8 Gurevich V, Thomas D. P. 1965; Pathogenesis of venous thrombosis in relation to its prevention by dextran and heparin. Journal of Laboratory and Clinical Medicine 66: 604.
9 Hume H. 1965; The relation of “Hypercoagulability” to thrombosis. Monogr. Surg. Sci 2: 133.
10 Isacson S, Nilsson I. M. 1972; Defective fibrinolysis in blood and vein walls in recurrent “idiopathic” venous thrombosis. Acta chirurgica Scandinavica 138: 313.
11 Kalendovsky Z, Austin J, Steele P. 1975; Increased platelet aggregability in young patients with stroke. Archives of Neurology 32: 13.
12 King J. B, Joffe S. N. 1974; The prediction of post-operative deep vein thrombosis, using a newly devised test of platelet function. Thrombosis et Diathesis Haemorrhagica 32: 503.
13 Mavor G. E, Mahaffy R. G, Walker M. G. et al. 1972; Peripheral venous scanning with ¹²⁵I-tagged fibrinogen. Lancet I: 661.
14 McKenna R, Miro-Quesada M, Bachmann F. 1973; Incidence of thromboembolism in patients with abnormally short activated partial thromboplastin time (APTT). Clinical Research 21: 832.
15 Negus D, Pinto D. J, Lequesne L. P. et al. 1968; ¹²⁵I-labelled fibrinogen in the diagnosis of deep-vein thrombosis and its correlation with phlebography. British Journal of Surgery 55: 835.
16 Nicolaides A. N, Kakkar V. V, Field E. S. et al. 1972; Venous stasis and deep vein thrombosis. British Journal of Surgery 59: 713.
17 Pilgeram L. O. 1974; Abnormalities in clotting and thrombolysis as a risk factor for stroke. Thrombosis et Diathesis Haemorrhagica 31: 245.
18 Pineo G. F, Regoeczi E, Hatton M. W. C. et al. 1973; The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas. Journal of Laboratory and Clinical Medicine 82: 255.
19 Spittel J. A, Pascuzi C. A, Thompson Jr. J. H. et al. 1960; Acceleration of early stages of coagulation in certain patients with occlusive arterial or venous diseases. Use of a modified thromboplastin generation test to evaluate clot acceleration. Proceedings of the Staff Meetings of the Mayo Clinic 35: 38.
20 Zuck F. T, Bergin J. J, Raymond J. M. et al. 1971; Implications of depressed antithrombin III activity associated with oral contraceptives. Surgery, Gynecology and Obstetrics with International Abstracts of Surgery 133: 609.